Neuropathology of CTE and Delayed Effects of TBI: Toward In-Vivo Diagnostics

CTE 的神经病理学和 TBI 的延迟效应:走向体内诊断

基本信息

项目摘要

DESCRIPTION (provided by applicant): The proposed project, "Neuropathology of CTE and Late Effects of TBI: Toward In-Vivo Diagnostics" is a multi- center and multi-disciplinary study designed to dramatically increase our understanding of chronic traumatic encephalopathy (CTE) and other late effects of traumatic brain injury (TBI). TBI is a major public health concern in the US, as the current prevalence of TBI in the US is unprecedented. Some TBI survivors experience particularly poor outcomes as they age; these include accelerated cognitive and health decline, dementia, and in some cases, CTE. CTE is thought to be a tauopathy but has been described only in convenience samples of people with repetitive head trauma. CTE is incompletely described in individuals with mild, moderate and severe TBI. The population incidence and prevalence, risk factors, and causal role of multifocal tauopathy on associated symptoms are unknown. Overlapping clinical features, postmortem pathologies and patterns of involvement exist in TBI, CTE, and Alzheimer's disease pose challenges to accurate diagnosis. Premortem diagnosis of CTE is currently impossible. The neuropathological consequences of single mild or moderate-severe TBI and its relationship with CTE and known dementias are unclear. The proposed project will leverage extensive resources from an ongoing population-based prospective cohort study of brain aging (Adult Changes in Thought; ACT, n=2,305) which includes excellent medical, behavioral, and genetic characterization of a cohort (20% of whom have a history of mild-moderate TBI) in addition to state-of-the-art neuropathology workup upon death. Neuropathological study of TBI effects can begin immediately in the existing ACT autopsy sample (n=489, 20% with TBI exposure). Additional cohorts of TBI- exposed individuals will come from the Brain Injury Research Center at Mount Sinai (n=150 individuals with moderate-severe TBI), the University of Texas Southwestern (n=50 retired boxers with repetitive TBI exposure), and the National Football League (n=76 retired players with repetitive TBI exposure). All participants in the proposed study (ACT and other sites) will undergo uniform harmonized neurobehavioral assessment (chosen to maximize correspondence with existing large-scale TBI and dementia studies), MRI scan, and genomic analysis. Those individuals who expire during the course of the study will undergo ex-vivo neuroimaging and extensive neuropathological exam using state-of-the-art techniques (such as Histelide) designed to quantify tau and A� in whole brain specimens. Only by examining postmortem pathology in a sample of individuals with varying levels of TBI exposure who are well characterized during life (as proposed herein) can postmortem pathology facilitate identification of in-vivo biomarkers that can act as diagnostic tools. This project represents the most systematic and scientifically rigorous effort to date to develop a more complete understanding of the long-term clinical and neuropathological sequelae of single and multiple TBI.
描述(由申请人提供):拟议项目“CTE 的神经病理学和 TBI 的晚期影响:迈向体内诊断”是一项多中心、多学科研究,旨在显着增进我们对慢性创伤性脑病 (CTE) 的了解以及创伤性脑损伤 (TBI) 的其他后期影响是一个主要的公共卫生问题。 在美国,目前 TBI 的患病率是前所未有的,一些 TBI 幸存者随着年龄的增长,会出现特别糟糕的结果;其中包括认知能力和健康状况加速下降、痴呆,在某些情况下,CTE 被认为是一种 tau 蛋白病。仅在重复性头部外伤患者的方便样本中进行了描述。在患有轻度、中度和重度 TBI 的个体中,CTE 的描述并不完整。多灶性 tau 病的人群发病率和患病率、危险因素以及相关临床症状的因果作用尚不清楚。 TBI、CTE 和阿尔茨海默病的特征、死后病理和参与模式对 CTE 的准确诊断目前是不可能的。单一轻度或中重度 TBI 的神经病理学后果及其与 CTE 和已知痴呆的关系。拟议的项目将利用正在进行的基于人群的大脑衰老前瞻性队列研究(成人思维变化;ACT,n=2,305)的广泛资源,其中包括出色的医学、行为和遗传研究。除了死亡时最先进的神经病理学检查之外,还可以在现有的 ACT 尸检样本中立即开始对队列进行表征(其中 20% 有轻度至中度 TBI 病史)。 489 人,其中 20% 患有 TBI 暴露),其他 TBI 暴露人群将来自西奈山脑损伤研究中心(n = 150 名中重度 TBI 患者)。德克萨斯大学西南大学(n = 50 名重复接触过 TBI 的退役拳击手)和国家橄榄球联盟(n = 76 名重复接触过 TBI 的退休运动员)拟议研究(ACT 和其他地点)的所有参与者都将接受统一的协调神经行为测试。评估(选择最大化与现有大规模 TBI 和痴呆研究的一致性)、MRI 扫描和基因组分析。在研究过程中过期的个体将接受离体神经成像和广泛的神经病理学检查。最先进的技术(例如 Histelide)旨在量化全脑标本中的 tau 和 A�,仅通过检查生前具有不同 TBI 暴露水平的个体样本的死后病理学(如提议的)。死后病理学可以促进体内生物标志物的识别,这些生物标志物可以作为诊断工具。该项目代表了迄今为止最系统和科学严谨的努力,旨在更全面地了解单一和多重的长期临床和神经病理学后遗症。创伤性脑损伤。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bringing posttraumatic sleep-wake disorders out of the dark.
将创伤后睡眠觉醒障碍带出黑暗。
  • DOI:
    10.1212/wnl.0000000000002710
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    9.9
  • 作者:
    Edlow,BrianL;Lammers,GertJan
  • 通讯作者:
    Lammers,GertJan
Intimate Partner Violence and Other Trauma Exposures in Females With Traumatic Brain Injury.
患有创伤性脑损伤的女性遭受亲密伴侣暴力和其他创伤。
  • DOI:
    10.1089/neu.2023.0225
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    deSouza,NicolaL;Kumar,RajG;Pruyser,Ariel;Blunt,EmilyE;Sanders,William;Meydan,Anogue;Lawrence,Phoebe;Venkatesan,UmeshM;MacDonald,ChristineL;Hoffman,JeanneM;Bodien,YelenaG;Edlow,BrianL;Dams-O'Connor,Kristen
  • 通讯作者:
    Dams-O'Connor,Kristen
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kristen Dams-O'Connor其他文献

Kristen Dams-O'Connor的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kristen Dams-O'Connor', 18)}}的其他基金

Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD)
利用现有的老龄化研究网络来调查 TBI 和 AD/ADRD 风险(了解 TBI
  • 批准号:
    10064985
  • 财政年份:
    2019
  • 资助金额:
    $ 147.95万
  • 项目类别:
Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD)
利用现有的老龄化研究网络来调查 TBI 和 AD/ADRD 风险(了解 TBI
  • 批准号:
    10709201
  • 财政年份:
    2019
  • 资助金额:
    $ 147.95万
  • 项目类别:
Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD)
利用现有的老龄化研究网络来调查 TBI 和 AD/ADRD 风险(了解 TBI
  • 批准号:
    10533343
  • 财政年份:
    2019
  • 资助金额:
    $ 147.95万
  • 项目类别:
Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD)
利用现有的老龄化研究网络来调查 TBI 和 AD/ADRD 风险(了解 TBI
  • 批准号:
    10341092
  • 财政年份:
    2019
  • 资助金额:
    $ 147.95万
  • 项目类别:
Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD)
利用现有的老龄化研究网络来调查 TBI 和 AD/ADRD 风险(了解 TBI
  • 批准号:
    9891932
  • 财政年份:
    2019
  • 资助金额:
    $ 147.95万
  • 项目类别:
Clinical & biological signatures of post-traumatic neurodegeneration: Toward in vivo diagnosis of the late effects of TBI.
临床
  • 批准号:
    9914761
  • 财政年份:
    2019
  • 资助金额:
    $ 147.95万
  • 项目类别:
Comprehensive Investigation of the Clinical Course of Traumatic Brain Injury
脑外伤临床病程的综合探讨
  • 批准号:
    8958717
  • 财政年份:
    2013
  • 资助金额:
    $ 147.95万
  • 项目类别:
Comprehensive Investigation of the Clinical Course of Traumatic Brain Injury
脑外伤临床过程的综合调查
  • 批准号:
    8785130
  • 财政年份:
    2013
  • 资助金额:
    $ 147.95万
  • 项目类别:
Comprehensive Investigation of the Clinical Course of Traumatic Brain Injury
脑外伤临床过程的综合调查
  • 批准号:
    8633829
  • 财政年份:
    2013
  • 资助金额:
    $ 147.95万
  • 项目类别:

相似国自然基金

PLAAT3降低介导线粒体降解异常在年龄相关性白内障发病中的作用及机制
  • 批准号:
    82301190
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
晶状体mtDNA氧化损伤修复与线粒体自噬的空间差异及其调控干预在年龄相关性白内障发病中的作用
  • 批准号:
    82171038
  • 批准年份:
    2021
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
FoxO3a通路抑制在年龄相关性白内障发病机制中的调控作用
  • 批准号:
    82070942
  • 批准年份:
    2020
  • 资助金额:
    57 万元
  • 项目类别:
    面上项目
ODRP泛素化经LECs外泌体释放和自噬降解调控年龄相关性白内障的发病
  • 批准号:
    81974129
  • 批准年份:
    2019
  • 资助金额:
    57 万元
  • 项目类别:
    面上项目
肠道微生态参与年龄相关性黄斑变性的发病机制及固本清目方的干预作用
  • 批准号:
    81973912
  • 批准年份:
    2019
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目

相似海外基金

Digital monitoring of autonomic activity to detect empathy loss in behavioral variant frontotemporal dementia
对自主活动进行数字监测以检测行为变异型额颞叶痴呆的同理心丧失
  • 批准号:
    10722938
  • 财政年份:
    2023
  • 资助金额:
    $ 147.95万
  • 项目类别:
The role of remission in the intergenerational transmission of alcohol use disorder: Course, context, and offspring outcomes
缓解在酒精使用障碍代际传播中的作用:病程、背景和后代结果
  • 批准号:
    10736096
  • 财政年份:
    2023
  • 资助金额:
    $ 147.95万
  • 项目类别:
Mapping the Neurobiological Risks and Consequences of Alcohol Use in Adolescence and Across the Lifespan
绘制青春期和整个生命周期饮酒的神经生物学风险和后果
  • 批准号:
    10733406
  • 财政年份:
    2023
  • 资助金额:
    $ 147.95万
  • 项目类别:
KLOTHO and Resilience to Synaptic Dysfunction in Preclinical AD
KLOTHO 和临床前 AD 中突触功能障碍的恢复力
  • 批准号:
    10587987
  • 财政年份:
    2023
  • 资助金额:
    $ 147.95万
  • 项目类别:
A Stage 1 Pilot Test for Feasibility and Efficacy of a Multi-Level Intervention To Increase Physical Activity in Adults with Intellectual Disability: Step it Up +
第一阶段试点测试多层次干预措施的可行性和有效性,以增加智力障碍成人的体力活动:加快步伐
  • 批准号:
    10585633
  • 财政年份:
    2023
  • 资助金额:
    $ 147.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了